A 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conserving Surgery and Radiation Therapy.
Vicini F, Shah C, Mittal K, Abraham J, Kruse M, Weinmann S, Leo M, Rabinovitch R, W?rnberg F, Whitworth PW, Czerniecki BJ, Shivers SC, Bremer T. A 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conserving Surgery and Radiation Therapy. Clin Breast Cancer. 2025 Feb; 25(2):e152-e158.e1.